Income Statement
MAIA BIOTECHNOLOGY, INC.
MAIA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Revenue
|
- | - | - | - |
|
Cost of Revenue
|
- | - | - | - |
|
Gross Profit
|
- | - | - | - |
|
Operating Expenses
|
24.27 | 16.96 | 20.18 | 16.18 |
|
Research & Development
|
14.55 | 10.01 | 11.11 | 8.93 |
|
Selling, General & Administrative
|
9.72 | 6.95 | 9.07 | 6.14 |
|
Other Operating Expenses
|
- | - | - | - |
|
Operating Income
|
-24.27 | -16.96 | -20.18 | -16.18 |
|
Non-Operating Income
|
- | - | - | - |
|
Interest Income
|
- | 0.32 | 0.03 | 0.00 |
|
Interest Expense
|
- | 0.00 | 0.01 | 0.01 |
|
Other Non-Op Income / Expense
|
- | - | - | - |
|
Income Before Tax
|
-22.39 | -23.30 | -19.80 | -15.80 |
|
Income Tax Expense
|
- | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - |
|
Net Income
|
-22.40 | -23.25 | -19.77 | -15.77 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY |
|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - |
|
EBITDA
|
-24.27 | -16.96 | -20.18 | -16.18 |
|
Earnings Per Share (Basic)
|
-0.70 | -1.05 | -1.49 | -1.75 |
|
Diluted EPS
|
-0.70 | -1.05 | -1.49 | -1.75 |
|
Weighted Average Shares
|
32.11 | 22.20 | 13.26 | 9.28 |
|
Diluted Weighted Avg Shares
|
32.11 | 22.20 | 13.26 | 9.28 |
|
Comprehensive Income
|
-22.42 | -23.27 | -19.77 | -16.24 |